All Resources
WHO Glove Use Information Leaflet
Outline of the evidence and considerations on medical glove use to prevent germ transmission
Poster
Environmental impact of personal protective equipment distributed for use by health and social care services in England in the first six months of the COVID-19 pandemic
The environmental impact of PPE is large and could be reduced through domestic manufacture, rationalising glove use, using reusables where possible and optimising waste management.
Article
Use of hand sanitiser as a potential substitution for nonsterile gloves in reducing carbon emissions.
Hence, in settings with frequent use of sharp equipment, open wounds, and mucus membrane exposure, examination gloves should be required. In cases where most pathogens cannot be transmitted through intact skin, the procedure is not seen as an exposure risk, and natural defences form an adequate barrier against transmittable disease, and sanitation of the hands might be an adequate and more ethical consideration for use. We have illustrated some examples to help readers decide when removing gloves for a procedure is appropriate and when it is not.
Article
The Environmental Impact of Hand Sanitizer Ethanol [Internet]. [cité 23 août 2023]. Disponible sur: https://mediahub.unl.edu/media/16495
My research’s purpose was to help fight the global COVID pandemic by helping ethanol producers produce USP grade ethanol as well as study the environmental impacts of producing USP grade ethanol.
Video
Turning lights into flights: estimating direct and indirect rebound effects for UK households
We estimate the direct and indirect rebound effects from energy efficiency improvements by UK households. We allow for the capital cost of the improvement, together with the emissions embodied in the relevant equipment. We find rebound effects to be relatively modest, in the range 5–15%. The anticipated shift towards a low carbon electricity system will lead to larger rebound effects.
Article
United Kingdom : The Gloves are Off
The Lead Nurse for Infection Prevention and Control and two Lead Practice Educators at Great Ormond Street Hospital NHS Foundation Trust (GOSH) addressed the over-use of non-sterile gloves through education and training. This has improved patient safety and experience and staff are now following evidence-based practice rather than wearing gloves out of habit.
Case Study

Lessons Learned from Unsuccessful Projects
This webinar, the fourth presentation in the “Reusables First” series, explores lessons learned from unsuccessful attempts to implement reusable products in healthcare settings. It highlights challenges such as increased workload, logistical complexity, and difficulty meeting staff needs. Speakers present case studies including reusable metal spoons, zero-waste yogurt containers, and reusable surgical textiles. Across organizations, common barriers included delays, loss of momentum, inconsistent stakeholder buy-in, and the lack of early cost analysis. The session emphasizes that sharing failures is important for helping other sustainability leaders avoid similar pitfalls and improve future implementation of reusable healthcare practices.
Webinar

Increasing reprocessing capacity with Jen Fraser, Island Health
This video provides an overview on the reusable level 2 isolation gowns program developed at Island Health in BC.
Video
Virtual Care Carbon Accounting
To help organizations measure and maximize these benefits, the CASCADES Virtual Care Carbon Accounting Tool (VCCAT) supports the estimation of travel-related carbon and financial impacts associated with virtual and in-person care. Combined with thoughtful implementation strategies, equitable access planning, and sustainable technology practices, virtual care can play a meaningful role in building a lower-carbon healthcare system
Playbook
Virtual Care Carbon Accounting Tool (for sites/units)
This tool will calculate: 1. The total carbon emissions saved from patient travel averted to and from your facility (in metric tonnes of CO2e) 2. The cost savings to patients from patient travel averted to and from your facility, including the cost of transit fare, gas, insurance, vehicle wear and tear, and parking (in Canadian dollars) 3. The total carbon and financial costs of in-person patient visits to and from your facility (in metric tonnes of CO2e) 4. The carbon and cost savings associated with virtual visits at various percentages of total visits (forecasting)
Tool